On November 5, 2021, the Centers for Medicare and Medicaid Services (CMS) published regulations that established the first ever federal vaccination requirements for health care provider staff. Drawing on its authority to establish patient health and safety standards, CMSs regulations require health care providers that participate in the Medicare and/or Medicaid programs to ensure that their staff are fully vaccinated against COVID-19. The new rule applies to staff who provide any care, treatment, or other services for providers or patients, including contractors and volunteers. The first phase of the new regulations was to take effect on December 6, 2021, with staff required to have received their first vaccine dose or requested an exemption by that date. However, the new regulations have been put on hold by federal courts, and the pending lawsuits create uncertainty about whether the new requirements ultimately will be implemented. This issue brief examines the new regulations, explains the status of the pending litigation, and identifies issues to watch.
CMS says it decided to require health care staff to be vaccinated because its earlier efforts to simply encourage vaccination have been insufficient to protect patient health and safety. For example, CMS cites data showing that COVID-19 cases in nursing homes surged with the rise of the Delta variant. The nursing home staff vaccination rate is nearly 76% nationally as of November 2021, with substantial variation by region. CMS concluded that standard federal requirements across provider types are needed because the existing patchwork of state and employer requirements has not been enough to bring the pandemic under control in health care settings. CMS notes that the vaccines are safe and highly effective at preventing severe illness and death, and unvaccinated staff can strain the health care system by transmitting COVID-19 to patients and having to miss work if they are recovering from COVID-19 or quarantining after exposure. CMS acknowledges that some staff may leave their jobs because they do not want to receive the vaccine but cites examples of vaccine mandates adopted by health systems in Texas and Detroit and a long-term care parent corporation with 250 facilities as well as the New York state health care worker mandate, all of which resulted in high rates of compliance and few employee resignations.
In response to the new regulations, 26 states led by Republican officials filed four federal lawsuits challenging the new rules (Table 1). While the specific legal claims vary somewhat among the different cases, the states essentially raise four major arguments. First, the states challenge the process that CMS used to adopt the new rules, arguing that CMS did not have good cause to forgo public notice and comment under the Administrative Procedure Act (APA). The states also argue that CMSs authority to establish health and safety regulations for Medicare and Medicaid providers does not allow it to adopt a broad vaccine requirement. And, they assert that CMSs new rule is arbitrary and capricious under the APA because CMS did not appropriately consider factors such as potential staffing disruptions, the limitations of vaccines, and the benefits of natural immunity. Finally, the states contend that the new rules violate Constitutional principles about the appropriate balance between federal and state government power. For example, the states argue that the rules place new conditions on state receipt of federal funds in violation of the Constitutions Spending Clause. The states also argue that the new rules improperly force states to administer federal regulations and unconstitutionally infringe on the states police powers to regulate for public health and safety.
On 12/13/21, the 8th Circuit in a 2:1 order denied CMSs motion to lift the preliminary injunction pending appeal.
On 12/6/21, the 11th Circuit in a 2:1 decision denied FLs motion for an injunction pending appeal.
Currently, CMS is unable to enforce the new rules nationwide, as a result of court orders, though circumstances may change as cases are appealed. To date, the 8th Circuit Court of Appeals has ruled that a Missouri federal courts decision preventing CMS from enforcing the new rules should remain in place while the appeal in that case is pending. Additionally, a federal court in Louisiana has blocked the new rules, while the 11th Circuit Court of Appeals has affirmed a Florida federal courts decision that the new regulations can be implemented while litigation is pending. (A fourth case in Texas federal court is on hold, pending further court action in the Louisiana case.) The Missouri courts preliminary injunction blocking the new rules applies in the 10 states that brought that case. However, the Louisiana court went further, applying its preliminary injunction not only to the 14 states in the case before it but also to all other states (except the 10 states in the Missouri case). This means that the new rules are now on hold even in states that did not challenge them. The Louisiana decision also put the new rules on hold in Florida, despite the Florida courts decision that the new rules should go into effect. However, as the 11th Circuit points out in its review of the Florida decision, the Louisiana decision could be changed when it is reviewed by the 5th Circuit on appeal. Specifically, the 11th Circuit found that it is reasonably likely that the 5th Circuit will conclude that the Louisiana court should not have applied its decision nationwide, even if the 5th Circuit ultimately upholds the Louisiana courts decision to block the new rules in the 14 states that brought the Louisiana case.
Court decisions in the lawsuits to date demonstrate opposing views about the scope of CMSs authority to respond to the pandemic and what constitutes the publics interest (Table 2). The 11th Circuits decision defers to the agencys expertise in the face of an unprecedented pandemic and notes that accepting Floridas arguments in opposition would amount to substituting the states views on epidemiology for the Secretarys judgment about the best way to protect the public from infection. By contrast, the Missouri and Louisiana courts fault the agency for not giving more credence to the arguments advanced by states that oppose CMSs rule. When articulating the publics interest in these issues, the 11th Circuit emphasizes the publics interest in slowing COVID-19 spread and protecting patients from preventable infection, while the Missouri and Louisiana decisions emphasize the publics interest in being free from vaccine requirements. The Louisiana courts characterization of the public interest is notable in light of its ultimate decision to block the rule in states that are not part of the litigation. The Louisiana court says that it entered a nationwide ruling because there are unvaccinated healthcare workers in other states who also need protection, though it does not discuss other aspects of the public interest, which may favor the rule.
The fate of CMSs new rules may ultimately be determined by the Supreme Court. The preliminary injunctions blocking implementation of the rules issued by Missouri and Louisiana courts currently are awaiting review on appeal by the 8th and 5th Circuits, respectively. If one or both appeals courts affirms the preliminary injunction, that decision would conflict with the 11th Circuits conclusion that the rule should not be blocked. A conflict among different appeals courts could increase the likelihood of the Supreme Court stepping in. As litigation to determine CMSs authority to mandate health care provider vaccines as part of its pandemic response continues to play out, the emergence of the Omicron variant is raising new questions about the pandemics future course. This development likely will further challenge CMS as it seeks to adopt policies to bring the pandemic under control which ultimately could prove successful but may never be implemented if courts decide to limit the agencys authority.
MO* and LA courts(granting preliminary injunction)
(A) Did CMS have good cause to issue the rule as interim final and bypass public notice and comment?
(B) Is CMSs rule within its authority to regulate Medicare and Medicaid as delegated by Congress?
(C) Is CMSs rule arbitrary and capricious?
(D) Does the new rule inappropriately infringe on state power?
(B) No. Though Congress has given CMS general authority to issue regulations about Medicare and Medicaid patient health and safety, CMS needs clear authorization to adopt a vaccine mandate because this involves powers of vast economic and political significance.
(C) Yes. CMS acknowledges that the extent to which vaccines prevent COVID-19 spread and their long-term effectiveness are unknown. CMS should not have used evidence about COVID-19s impact on long-term care facilities to extrapolate about effects on other providers that do not care for vulnerable patients. CMSs rule is too broad because it acknowledges that children are less affected by COVID-19 but subjects pediatric facilities to the new rule. CMS did not appropriately consider alternatives such as testing or natural immunity or the harm the rule will cause by exacerbating worker shortages.
(D) The preliminary injunction decisions do separately analyze this issue in detail, though the LA court notes that the rule infringes on state power because it specifically preempts state law.
(B) Yes. Federal law expressly authorizes CMS to establish Medicare and Medicaid provider health and safety standards. Congress did not need to be more specific because until now, vaccination has not been a political issue and instead has been regarded as a common-sense measure designed to prevent healthcare workers, whose job it is to improve patients health, from making them sicker.
(C) No. The court should defer to CMSs decision about how to best protect patients, which is supported by ample evidence. CMS cites evidence showing that health care workers respond to mandates by getting vaccinated instead of leaving their jobs.
(D) While not separately analyzed by the 11th Circuit, the court notes that federal law preempts conflicting state law.
Read more here:
- Covid-19 diagnostic based on MIT technology might be tested on patient samples soon - The MIT Tech [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Dutch researchers first to find Covid-19 antibodies: Report - NL Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Getting Viral: Why COVID-19 is Such a Threat to the 60+ Plus Population and Why the Response May Make It Worse - CounterPunch [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- U.K. Scientists Paying People $4,000 to Get Infected with Coronaviruses - Newsweek [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Youre Likely to Get the Coronavirus - The Atlantic [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Mountain West Scientists Contributing To The Race For A COVID-19 Vaccine - KUNC [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- China Threatens to Withhold COVID-19 Vaccine - The - The Floridian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Look for novel coronavirus treatments first, experts say, and vaccines are further off than you think - FiercePharma [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- COVID-19 vaccine will take at least two years to develop: health officials - The Hindu [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- 'Where's the money?' Inside GeoVax, one lab working to create a COVID-19 vaccine - wgxa.tv [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Homeland Security News Wire: COVID-19 Virus Isolated Better Testing, Treatments, Vaccines Are Near - Los Alamos Daily Post [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- With the coronavirus, drug that once raised global hopes gets another shot - STAT [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Farmington biotech teams with Yale to pursue COVID-19 vaccine - Hartford Business [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Father and daughter virologists working on vaccine for COVID-19 - National Observer [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Sanofi exploring possibility of COVID-19 vaccine that would be produced in Pa. - Bucks County Courier Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- EMA offers free advice to COVID-19 vaccine and therapeutic developers - European Pharmaceutical Review [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Italy COVID-19 total tops 10000; funding grows for treatments, vaccines - CIDRAP [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Free Tests, Free Vaccines: Remove the Wealth Barriers to Fighting COVID-19 - The Nation [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Inovio Pharm gets $5M from Gates Foundation to further COVID-19 vaccine project - The San Diego Union-Tribune [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- On the hunt for a Covid-19 vaccine - Vantage [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- When will a coronavirus vaccine be ready? - The Guardian [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Coronavirus vaccine: why will it take so long to create? - Los Angeles Times [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Covid-19 vaccine in development by J&J and BIDMC. - Pharmaceutical Technology [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- First COVID-19 vaccine trial starts Monday in Seattle, government official says - KOMO News [Last Updated On: March 16th, 2020] [Originally Added On: March 16th, 2020]
- Others at Kansas home tied to COVID-19 death tested negative - hays Post [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Commentary: Is the UK's herd immunity strategy to combat COVID-19 worth pursuing? - CNA [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 5 Promising Covid-19 Vaccines and Drugs That Could End Coronavirus Pandemic - Observer [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First human trial of COVID-19 vaccine gets under way in the US - EWN [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Government official: First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine - Associated Press [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- First stage of COVID-19 vaccine testing gets under way - The Mercury News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The Race Is On To Find A Vaccine For COVID-19 - WCCO | CBS Minnesota [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- 10 Positive Updates on the COVID-19 Outbreaks From Around the World - Good News Network [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Authorities warn of scam callers seeking sensitive information to reserve a vaccine for COVID-19 - FOX 13 Tampa Bay [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Still on Phase 1 and Might Take 18 Months From Now to Create Says Global Health Official - Tech Times [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Army command continues work on COVID-19 vaccine, treatment | Hospital near Fort Detrick to setup drive-through testing site - WUSA9.com [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Australian researchers have made an important discovery in the race to find a COVID-19 vaccine - SBS News [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer - CNBC [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- Covid-19 outbreak: the key to quicker vaccine development - Pharmaceutical Technology [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- COVID-19 Vaccine Test Begins With U.S. Volunteer | Time [Last Updated On: March 17th, 2020] [Originally Added On: March 17th, 2020]
- The FDA Regulatory Landscape for Covid-19 Treatments and Vaccines - JD Supra [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Montgomery Co. life science companies work together on COVID-19 vaccine - WDVM 25 [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Meet the volunteers testing the new experimental COVID-19 vaccine - CTV News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- The U.S. Should Make COVID-19 Testing, Prevention And Care Free To All - WBUR [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Biotech That Doubled on Covid-19 Frenzy Readies New Flu Vaccine - Bloomberg [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Jones sponsors bill for insurance plans to cover COVID-19 vaccines when they're available - alreporter.com [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- Seattle volunteers receive world's first experimental COVID-19 vaccine - KOMO News [Last Updated On: March 18th, 2020] [Originally Added On: March 18th, 2020]
- What scientists are working on to find a cure for coronavirus COVID-19 - ABC News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- This study shows how difficult it will be to find Covid-19 vaccine volunteers - Ladders [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Differences between COVID-19 and flu? We have no immunity or vaccine for the new virus, local expert says - WFTV Orlando [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- GeekWire Podcast: Bill Gates on COVID-19, gig workers in peril, and more on the coronavirus crisis - GeekWire [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus vaccine: Expert warns that a usable Covid-19 vaccination won't be available for at least a year - inews [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Is Deadlier Than The Flu. How Else Do They Differ? : Goats and Soda - NPR [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Is This 'Good News' List About the COVID-19 Pandemic Accurate? - Snopes.com [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- WHO expert: Finding and distributing COVID-19 vaccine in 18 months would be 'historic' - EURACTIV [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19: 5 reasons to be cautiously hopeful - Medical News Today [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Scammers are trying to trick people into reserving a COVID-19 vaccine over the phone - The Verge [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Coronavirus: How scientists are racing to find a Covid-19 vaccine - ITV News [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 Vaccines Are Coming, but Theyre Not What You Think - The Atlantic [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- First patients injected with potential COVID-19 vaccine in ... [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- COVID-19 vaccine - Wikipedia [Last Updated On: March 21st, 2020] [Originally Added On: March 21st, 2020]
- Researchers working to fast-track a COVID-19 vaccine - FOX 9 [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Projects awarded 10.5m to boost Covid-19 vaccine research - National Health Executive [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- CureVac denies reports that Trump admin sought to acquire Covid-19 vaccine rights - MedCity News [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Cork workers to be involved in race to find vaccine for Covid-19 - Echo Live [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- COVID-19 Drugs And Vaccines Showing Promise - WVXU [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall - TechCrunch [Last Updated On: March 23rd, 2020] [Originally Added On: March 23rd, 2020]
- Beware of Fraudulent Coronavirus Tests, Vaccines and Treatments - WBIW.com [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Singapore scientists plan to start testing COVID-19 vaccine this year: Gan Kim Yong - CNA [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Meet the scientists contributing to race for COVID-19 vaccine - Study International News [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- The Covid-19 Vaccine: How Much Will It Cost & Who Will Have Access? - KALW [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Scientists race to find COVID-19 vaccine, as global cases of infection climb - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Soligenix Inc. Heat-Stabilization Platform Evaluating Use With COVID-19 Vaccine; Zacks Small-Cap Research Increases Valuation To $12.00 Per Share -... [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Inovio Pharmaceuticals Gets Help From Ology Bioservices and the Defense Department with Its COVID-19 Vaccine Candidate - The Motley Fool [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- New coronavirus research suggests vaccines developed to treat it could be long-lasting - TechCrunch [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- Hoth Surges on Collaboration With Voltron for COVID-19 Vaccine - Yahoo Finance [Last Updated On: March 25th, 2020] [Originally Added On: March 25th, 2020]
- UVM Researcher Offers Insights on Vaccines and COVID-19 - Seven Days [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- 20 Indian institutes working to find Covid-19 vaccine, IITs focused on portable ventilators - ThePrint [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Researchers in Pittsburgh, Paris and Vienna Win Grant for COVID-19 Vaccine - UPJ Athletics [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]
- Research Team in Race to Develop COVID-19 Vaccine and Treatments - USC Viterbi School of Engineering [Last Updated On: March 27th, 2020] [Originally Added On: March 27th, 2020]